Search

Author/Creator Rossig, C.

1. Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T‐lymphocyte recovery. Issue 1 (12th January 2015)

Authors:
Kerl, K.; Ehlert, K.; Brentrup, A.; Schiborr, M.; Keyvani, K.; Becker, K.; Rossig, C.; Groll, A.H.
Journal:
Transplant infectious disease
Issue:
Volume 17:Issue 1(2015)
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria. Issue 10 (5th June 2013)

Authors:
Rossig, C.; Juergens, H.; Schrappe, M.; Moericke, A.; Henze, G.; von Stackelberg, A.; Reinhardt, D.; Burkhardt, B.; Woessmann, W.; Zimmermann, M.; Gadner, H.; Mann, G.; Schellong, G.; Mauz‐Koerholz, C.; Dirksen, U.; Bielack, S.; Berthold, F.; Graf, N.; Rutkowski, S.; Calaminus, G.
Journal:
Pediatric blood & cancer
Issue:
Volume 60:Issue 10(2013:Oct.)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH‐HD2002 trial. Issue 3 (14th November 2018)

Authors:
Kurch, L.; Hasenclever, D.; Kluge, R.; Georgi, T.; Tchavdarova, L.; Golombeck, M.; Sabri, O.; Eggert, A.; Brenner, W.; Sykora, K.W.; Bengel, F.M.; Rossig, C.; Körholz, D.; Schäfers, M.; Feuchtinger, T.; Bartenstein, P.; Ammann, R.A.; Krause, T.; Urban, C.; Aigner, R.
Journal:
Pediatric blood & cancer
Issue:
Volume 66:Issue 3(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY. (23rd June 2022)

Authors:
Vora, A.; Bhatla, T.; Teachey, D.; Bautista, F.; Moppett, J.; Velasco Puyó, P.; Micalizzi, C.; Rossig, C.; Shukla, N.; Gilad, G.; Locatelli, F.; Baruchel, A.; Zwaan, C. M.; Raetz, E. A.; Bandyopadhyay, N.; Lopez Solano, L.; Dennis, R. M.; Carson, R.; Hogan, L. E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity. (24th October 2016)

Authors:
Herzog, J.; Klot-Heydenfeldt, F. von; Jabar, S.; Ranft, A.; Rossig, C.; Dirksen, U.; Van den Brande, J.; D'Incalci, M.; Luettichau, I. von; Grohar, P. J.; Berdel, W. E.; Burdach, St.
Other Names:
Randall R. Lor Academic Editor.
Journal:
Sarcoma
Issue:
Volume 2016(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗